Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 0.45.

  • Treace Medical Concepts' Equity Ratio fell 792.07% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year decrease of 792.07%. This contributed to the annual value of 0.52 for FY2024, which is 503.32% down from last year.
  • Per Treace Medical Concepts' latest filing, its Equity Ratio stood at 0.45 for Q3 2025, which was down 792.07% from 0.47 recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Equity Ratio high stood at 0.72 for Q2 2021, and its period low was 0.02 during Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Equity Ratio value was 0.52 (recorded in 2024), while the average stood at 0.51.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 346076.71% in 2021, then plummeted by 4381.9% in 2022.
  • Over the past 5 years, Treace Medical Concepts' Equity Ratio (Quarter) stood at 0.66 in 2021, then crashed by 42.41% to 0.38 in 2022, then soared by 43.86% to 0.55 in 2023, then fell by 5.03% to 0.52 in 2024, then decreased by 12.76% to 0.45 in 2025.
  • Its Equity Ratio was 0.45 in Q3 2025, compared to 0.47 in Q2 2025 and 0.51 in Q1 2025.